Neuroprotective Agents in the Intensive Care Unit: -Neuroprotective Agents in ICU
- PMID: 30652049
- PMCID: PMC6333194
- DOI: 10.3831/KPI.2018.21.026
Neuroprotective Agents in the Intensive Care Unit: -Neuroprotective Agents in ICU
Abstract
Neuroprotection or prevention of neuronal loss is a complicated molecular process that is mediated by various cellular pathways. Use of different pharmacological agents as neuroprotectants has been reported especially in the last decades. These neuroprotective agents act through inhibition of inflammatory processes and apoptosis, attenuation of oxidative stress and reduction of free radicals. Control of this injurious molecular process is essential to the reduction of neuronal injuries and is associated with improved functional outcomes and recovery of the patients admitted to the intensive care unit. This study reviews neuroprotective agents and their mechanisms of action against central nervous system damages.
Keywords: intensive care unit; neuroprotection; stroke.
Conflict of interest statement
Conflict of interest The authors declare that there are no conflicts of interest.
Similar articles
-
Propofol: an anesthetic possessing neuroprotective effects.Eur Rev Med Pharmacol Sci. 2015 Apr;19(8):1520-9. Eur Rev Med Pharmacol Sci. 2015. PMID: 25967729 Review.
-
Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group.Cerebrovasc Dis. 1998 Jan-Feb;8(1):59-72. doi: 10.1159/000015817. Cerebrovasc Dis. 1998. PMID: 9645985 Review.
-
Endogenous Neuroprotective Molecules and Their Mechanisms in the Central Nervous System.Biol Pharm Bull. 2015;38(8):1104-8. doi: 10.1248/bpb.b15-00361. Biol Pharm Bull. 2015. PMID: 26235573 Review.
-
JNK3 inhibitors as promising pharmaceuticals with neuroprotective properties.Cell Adh Migr. 2024 Dec;18(1):1-11. doi: 10.1080/19336918.2024.2316576. Epub 2024 Feb 15. Cell Adh Migr. 2024. PMID: 38357988 Free PMC article. Review.
-
The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: Evidence from in vitro and in vivo studies.Eur J Neurosci. 2021 Nov;54(9):7006-7047. doi: 10.1111/ejn.15474. Epub 2021 Oct 25. Eur J Neurosci. 2021. PMID: 34561931 Review.
Cited by
-
Perspectives on the Molecular Mediators of Oxidative Stress and Antioxidant Strategies in the Context of Neuroprotection and Neurolongevity: An Extensive Review.Oxid Med Cell Longev. 2022 Aug 26;2022:7743705. doi: 10.1155/2022/7743705. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36062188 Free PMC article. Review.
-
Beyond survival: understanding post-intensive care syndrome.Acute Crit Care. 2024 May;39(2):226-233. doi: 10.4266/acc.2023.01158. Epub 2024 May 24. Acute Crit Care. 2024. PMID: 38863353 Free PMC article.
-
From Conservative Measures to Surgical Interventions, Treatment Approaches for Cubital Tunnel Syndrome: A Comprehensive Review.Cureus. 2023 Dec 29;15(12):e51262. doi: 10.7759/cureus.51262. eCollection 2023 Dec. Cureus. 2023. PMID: 38288228 Free PMC article. Review.
-
Propofol and α2-Agonists Attenuate Microglia Activation and Restore Mitochondrial Function in an In Vitro Model of Microglia Hypoxia/Reoxygenation.Antioxidants (Basel). 2022 Aug 28;11(9):1682. doi: 10.3390/antiox11091682. Antioxidants (Basel). 2022. PMID: 36139756 Free PMC article.
-
Targeting Mitochondrial and Brain Injury Markers in Acquired Brain Injuries: A Randomized, Double-Blind, Placebo-Controlled Study with Melatonin.Adv Pharm Bull. 2022 Jan;12(1):118-127. doi: 10.34172/apb.2022.013. Epub 2021 Apr 3. Adv Pharm Bull. 2022. PMID: 35517892 Free PMC article.
References
-
- Jain KK. The handbook of neuroprotection. Humana; New York: 2011. - DOI
Publication types
LinkOut - more resources
Full Text Sources